Hanwha Q CELLS to Attend 29th Annual ROTH Conference
Get Alerts HQCL Hot Sheet
Join SI Premium – FREE
SEOUL, South Korea, March 6, 2017 /PRNewswire/ -- Hanwha Q CELLS Co., Ltd. ("Hanwha Q CELLS" or the "Company") (NASDAQ: HQCL), one of the world's largest photovoltaic manufacturers of high-quality, high-efficiency solar modules, today announced that it will attend 29th Annual ROTH Conference and will conduct one-on-one meetings.
Sponsored by ROTH Capital Partners, the ROTH conference will be held between March 12-15, 2017 at The Ritz Carlton, Laguna Niguel in Orange County, California. This conference is by invitation only and please contact [email protected] or your ROTH representative at (800) 933-6830 for more information or to schedule a meeting.
About Hanwha Q CELLS
Hanwha Q CELLS Co., Ltd. (NASDAQ: HQCL) is one of the world´s largest and most recognized photovoltaic manufacturers for its high-performance, high-quality solar cells and modules. It is headquartered in Seoul, South Korea (Global Executive HQ) and Thalheim, Germany (Technology & Innovation HQ) with its diverse international manufacturing facilities in Malaysia and China. Hanwha Q CELLS offers the full spectrum of photovoltaic products, applications and solutions, from modules to kits to systems to large scale solar power plants. Through its growing global business network spanning Europe, North America, Asia, South America, Africa and the Middle East, the company provides excellent services and long-term partnership to its customers in the utility, commercial, government and residential markets. Hanwha Q CELLS is a flagship company of Hanwha Group, a FORTUNE Global 500 firm and a Top 10 business enterprise in South Korea. For more information, visit: http://www.hanwha-qcells.com/.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hanwha-q-cells-to-attend-29th-annual-roth-conference-300418512.html
SOURCE Hanwha Q CELLS Co., Ltd.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock and Warrants
- Olympia Financial Group Inc. Announces Second Quarter 2026 Results
- Belite Bio Reports Unaudited Second Quarter 2026 Financial Results and Provides a Corporate Update
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share